Related Experiment Video
Updated: Apr 18, 2026

Monitoring Immune Cells Trafficking Fluorescent Prion Rods Hours after Intraperitoneal Infection
Published on: November 19, 2010
hTERT-immortalized ovine microglia propagate natural scrapie isolates
Juan F Muñoz-Gutiérrez1, David A Schneider2, Timothy V Baszler1
1Department of Microbiology and Pathology, College of Veterinary Medicine, Washington State University, PO Box 64700, Pullman, WA 99164-7010, United States.
Abstract:
Ex vivo propagation of natural prion isolates (i.e., propagated solely in the natural host) is crucial for the characterization and study of transmissible spongiform encephalopathies (TSEs). Several well-established, prion-permissive cell culture systems are available; however, only a few cell lines are permissive to natural prion isolates and these cells are not pathophysiologically relevant (e.g., renal epithelium and fibroblast-like cells). Therefore, a pathophysiologically relevant cell line derived from a natural TSE host could be used for propagation of natural prion isolates. In this study, ovine brain macrophages (microglia) were immortalized by transfection with the human telomerase reverse transcriptase (hTERT) gene to identify cell lines (hTERT-microglia) permissive to natural scrapie prion isolates. Following transfection, hTERT-microglia were passaged up to 100 times and their lifespan was significantly longer compared to parental cells (Fisher's exact test, P<0.001). Multiple sublines were permissive to cell culture-adapted prions; two sublines were also permissive to natural scrapie isolates (i.e., derived from brain homogenates of sheep infected with scrapie). Prion infectivity and partial protease resistance of the prion protein were maintained in hTERT-microglia. Comparisons between scrapie-permissive and non-permissive hTERT-microglia sublines revealed that overall quantity of the normal cellular prion protein was not associated with prion permissiveness. The use of hTERT-microglia in future TSE studies may be more germane to the characterization of the cellular and subcellular pathophysiology of natural scrapie prion isolates and to investigate host-specific factors involved in prion replication.
Insights
Researchers developed immortalized ovine microglia (hTERT-microglia) capable of propagating natural scrapie prion isolates. This breakthrough offers a relevant cell model for studying transmissible spongiform encephalopathies (TSEs) and prion disease.
Area of Science:
- Neuroscience
- Cell Biology
- Veterinary Medicine
Background:
- Ex vivo prion propagation is vital for studying transmissible spongiform encephalopathies (TSEs).
- Existing prion-permissive cell lines lack pathophysiological relevance to natural prion isolates.
- A need exists for cell lines derived from TSE hosts that can propagate natural prions.
Purpose of the Study:
- To develop and characterize immortalized ovine microglia (hTERT-microglia) for permissive propagation of natural scrapie prion isolates.
- To establish a pathophysiologically relevant cell model for TSE research.
Main Methods:
- Ovine brain macrophages (microglia) were immortalized using the human telomerase reverse transcriptase (hTERT) gene.
- Transfected cells (hTERT-microglia) were passaged and tested for permissiveness to natural and adapted scrapie prion isolates.
- Prion infectivity and protease resistance were assessed in permissive cell sublines.
Main Results:
- hTERT-microglia exhibited significantly extended lifespan compared to parental cells.
- Two hTERT-microglia sublines demonstrated permissiveness to natural scrapie prion isolates.
- Prion infectivity and partial protease resistance were maintained in these cells.
- The quantity of normal cellular prion protein did not correlate with prion permissiveness.
Conclusions:
- Immortalized hTERT-microglia provide a relevant cell model for propagating natural scrapie prion isolates.
- This model can advance the study of TSE pathophysiology and host-specific prion replication factors.
- Future research can utilize hTERT-microglia for detailed characterization of prion diseases.

